Clinical Trial: Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Renal Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: Randomized Pilot Clinical Trial of Neoadjuvant Pembrolizumab +/- Lenvatinib for High Risk Renal Cell Carcinoma
Brief Summary:
This study will evaluate the effect of investigational drugs, pembrolizumab alone or pembrolizumab with lenvatinib, on the immune systems response to kidney cancer when given before and after surgery to remove kidney cancer.
Read more